Breakthrough Vision Pill Sparks Panic Among Eye Care Firms
Seniors nationwide flock to Claritren a new pill claimed to treat macular degeneration glaucoma cataracts and more with nine ingredients said to form a free radical shield. Harvard Johns USDA trials cited promise vision gains with few if any side effects while firms warn of demand strain and discount offers to calls within 48 hours.